-
-
Call more information
660-596-2224 -
The US Food and Drug Administration (FDA) is warning that the type 2 diabetes medicines sitagliptin, saxagliptin, linagliptin, and alogliptin may cause joint pain that can be severe and disabling. The FDA has added a new Warning and Precaution about this risk to the labels of all medicines in this drug class, dipeptidyl peptidase-4 (DPP-4) […]
Read MoreIn carefully selected patients, minimally invasive surgery is enabling physicians to stop strokes in their tracks. As more patients undergo such procedures, physicians are debating the best way to anesthetise them. Should patients be put under general anaesthesia or should they undergo conscious sedation? In the September, 2015 issue of the Journal of Stroke and […]
Read MoreHospitals and other healthcare facilities should stop using the Symbiq Infusion System manufactured by Hospira because hackers could gain access to the device and give patients life-threatening overdoses or underdoses of drugs, the US Food and Drug Administration (FDA) announced today. Hospira has ceased making this line of computerized infusion pumps for unrelated reasons and […]
Read MoreMusic played during surgery can interfere with team communication, yet it is seldom recognized as a potential safety hazard, according to the authors of a study published in the August Journal of Advanced Nursing. Sharon-Marie Weldon, RN, senior research officer/nurse from the Department of Cancer and Surgery, Imperial College London, United Kingdom, and colleagues studied […]
Read MoreThe American Nurses Association (ANA) will no longer tolerate violence of any kind against nurses in the workplace, according to a new position statement developed by its Professional Issues Panel on Incivility, Bullying, and Workplace Violence. “Taking this clear and strong position is critical to ensure the safety of patients, nurses and other health care […]
Read More